SUNNYVALE, Calif., Oct. 28, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) – Thailand's Lopburi Cancer Hospital, a center of excellence for cancer treatment, is the first in the Asia-Pacific region to clinically use the combination of RaySearch's treatment planning system RayStation&re

MALVERN, Pa., Oct. 28, 2019 /PRNewswire/ -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced a partnership with Success TMS, a healthcare provider specializing in transcrani

DUBLIN, Oct. 28, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced that Endo Aesthetics launched a "Redefining Scientific Artistry" campaign at the Annual Meeting of the American Society for Dermatologic Surgery (ASDS) held in Chicago, IL from October 24 - 27, 2019. The campaign launched wi

NEW HAVEN, Conn., Oct. 28, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurologic and neuropsychiatric diseases, today announced that it has completed enrollment in its pivotal Phase 3 clinical trial assessing th

CALGARY and LAVAL, QC, Oct. 28,  2019 /PRNewswire/ - Sundial Growers Inc. (Nasdaq: SNDL) ("Sundial"), a Canadian licensed producer of cannabis and Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) ("Crescita"), a Canadian commercial dermatology company, today announced a development and licensing agreement (the "Agreement") granting Sundial the world

BROOKLYN, N.Y., Oct. 28, 2019 /PRNewswire/ -- 40 years ago, a public engine was sparked by the radical notion Brooklyn communities could be self-sustaining. CABS Corporation (Community Action Program of Bedford Stuyvesant, Inc.) has served as a business incubator, an AIDS/HIV advocate, Nursing Home and most prominently as a Licensed Home

With Remediation Plan in Place, Company is Focused Upon Board Renewal

WESTON, Fla., Oct. 28, 2019 /PRNewswire/ -- ZyVersa Therapeutics, Inc., (ZyVersa) a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, is pleased to announce that Stephen C. Glover, ZyVersa's Co-Founder, Chief Executive Officer, and President, is an invited sp

CARLSBAD, Calif., Oct. 28, 2019 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, announced today that Ionis scientists will give presentations highlighting antisense medicines for neurological diseases and two LIgand Conjugated Antisense (LICA) medicines, IONIS-FXI-LRx and IONIS-TMPR

VANCOUVER and SAN DIEGO, Oct. 28, 2019 /PRNewswire/ - Phivida Holdings Inc. (CSE:VIDA; OTC:PHVAF) ("Phivida"), is pleased to announce that it has signed an agreement with Gotham Brands ("Gotham") to handle sales, merchandising and distribution in New York City